Trial EudraCT 2021-002348-57
Publication Bonelli M, medRxiv, 2021
Primary outcome on the report: Difference in antibody seroconversion rates between the vector and mRNA vaccinated groups

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.